Post-radiotherapy cribriform-morular thyroid carcinoma
Journal of Clinical Laboratory Analysis, cilt.37, sa.1, 2023 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 37 Sayı: 1
- Basım Tarihi: 2023
- Doi Numarası: 10.1002/jcla.24819
- Dergi Adı: Journal of Clinical Laboratory Analysis
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Analytical Abstracts, CAB Abstracts, CINAHL, MEDLINE, Veterinary Science Database, Directory of Open Access Journals
- Anahtar Kelimeler: cribriform-morular thyroid carcinoma, post-radiotherapy thyroid carcinoma, thyroid carcinoma
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Background: According to the new 2022 World Health Organization classification of endocrine tumors, thyroid malignancy, formerly known as the cribriform-morular variant of papillary thyroid carcinoma, is now categorized as differentiated thyroid malignancy; it is, at present, called cribriform-morular thyroid carcinoma and classified as a tumor of unknown histogenesis. Case Report: In this case report, we report on a 15-year-old patient who underwent external radiotherapy to the neck for Hodgkin's disease and developed cribriform-morular thyroid carcinoma 5 years after radiotherapy. Conclusions: We believe that cribriform-morular thyroid carcinoma with diffuse nuclear beta-catenin expression has exciting and unresolved uncertainties that may affect disease prognosis and follow-up for cytopathologists and endocrinologists.